Scan a productBook a demo

Notes on product trust, from the team building it.

Serialization, GS1 standards, fraud signals and the regulation behind them — written for the people who run production lines, not for search engines.

LATEST
DSCSA Compliance for Indian Pharma Exporters: Serialization, EPCIS and the Deadlines That Matter
Compliance9 min

DSCSA Compliance for Indian Pharma Exporters: Serialization, EPCIS and the Deadlines That Matter

What the US Drug Supply Chain Security Act asks of an Indian manufacturer, the exemption deadlines that ended in 2025 and 2026, how EPCIS data exchange works, and how to run DSCSA and Schedule H2 on one packaging line.

9 Sept 2026Read
India's Pharma QR Mandate Expands: Vaccines and Anti-Cancer Drugs Face the 2027 Deadline
Compliance7 min

India's Pharma QR Mandate Expands: Vaccines and Anti-Cancer Drugs Face the 2027 Deadline

India's drug QR-code rules are expanding beyond Schedule H2: vaccines, anti-cancer drugs and narcotics need GS1-based QR codes from July 2027, antimicrobials from 2028. A practical readiness guide for manufacturers.

12 Jul 2026Read
GS1 Sunrise 2027: What Indian Manufacturers Must Do Before the 2D Barcode Switch
Compliance7 min

GS1 Sunrise 2027: What Indian Manufacturers Must Do Before the 2D Barcode Switch

Retail point-of-sale worldwide goes 2D-capable by end-2027. What GS1 Sunrise 2027 means for Indian manufacturers: GTINs, Digital Link QR codes, dual marking and a step-by-step transition plan.

11 Jul 2026Read